Xalud Therapeutics
Xalud Therapeutics is developing a non-viral gene therapy targeting immune modulation, harnessing the power of interleukin-10.
Industry: Therapeutics
Funding Stage: Series B Round or beyond
- Home
- 麻豆影院 Us
- Get Started
-
For University Innovators
For University Innovators
Intellectual Property (IP) ManagementEntrepreneurial TrainingFunding Opportunities & Support -
For Investors & Partners
For Investors & Partners
Explore our Technologies and StartupsNetworking and Showcases -
Opportunities & Events
Opportunities & Events
The Insider E-Newsletter: Get the latest opportunities and events right in your inbox. Subscribe
Signature Venture Partners Programming - Newsroom
- Contact Us